Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

530.10 +8.88 (+1.70%)

Streaming Delayed Price Updated: 12:17 PM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating ↗

May 14, 2024

On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79.

Via Investor's Business Daily

3 Biotech Stocks to Double Your Money in the Next 24 Months ↗

May 06, 2024

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.

Via InvestorPlace

The Latest Analyst Ratings For United Therapeutics ↗

May 02, 2024

Via Benzinga

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity ↗

May 01, 2024

United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.

Via Benzinga

UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

UTHR stock results show that United Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗

May 01, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss United Therapeutics Stock ↗

February 22, 2024

Via Benzinga

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

May 01, 2024

From United Therapeutics Corporation

Via Business Wire

CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

April 26, 2024

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

April 24, 2024

From United Therapeutics Corporation

Via Business Wire

NASDAQ:UTHR stands out as a stock that provides good value for the fundamentals it showcases. ↗

April 24, 2024

Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued.

Via Chartmill

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Earnings Outlook For United Therapeutics ↗

February 20, 2024

Via Benzinga

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

April 16, 2024

From United Therapeutics Corporation

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 26, 2024

Via Benzinga

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation

March 26, 2024

From United Therapeutics Corporation

Via Business Wire

The Bargain Hunter’s Portfolio: 7 Smart Stock Buys for the Shrewd Investor ↗

March 25, 2024

Although several companies have seen their valuations blossom, you can still find bargain stocks if you know where to look.

Via InvestorPlace

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

March 25, 2024

From United Therapeutics Corporation

Via Business Wire

The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024 ↗

March 13, 2024

Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.

Via InvestorPlace

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making ↗

March 05, 2024

These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

Via InvestorPlace

United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024

March 05, 2024

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference

February 27, 2024

From United Therapeutics Corporation

Via Business Wire

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff ↗

February 26, 2024

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

Via InvestorPlace

United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings ↗

February 21, 2024

Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...

Via Benzinga

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

February 21, 2024

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process

February 21, 2024

From United Therapeutics Corporation

Via Business Wire

This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate ↗

February 12, 2024

United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:

Via Benzinga

Topics Intellectual Property

Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday ↗

February 12, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January ↗

January 25, 2024

These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

Via InvestorPlace

Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market ↗

January 16, 2024

In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.